A foreign establishment that makes a drug or a medical device for the U.S. market generally has to register with FDA and list the product — drugs under 21 CFR Part 207, devices under 21 CFR Part 807. For devices, the U.S. initial importer registers too. Registration and listing are separate from premarket clearance or approval.
Part 207 reaches foreign manufacturers, repackers, relabelers, and salvagers of human drugs, unless they fall in one of the exempt classes in section 207.13. A covered establishment registers with FDA and lists its drugs. This is establishment registration and drug listing — an identification requirement — and the rule is explicit that it does not relieve anyone of other statutory or regulatory obligations.
For devices, the owner or operator of an establishment that manufactures, prepares, or processes a device intended for human use registers and submits a device list, unless exempt under section 807.65. Part 807 also names the U.S. initial importer as a party that registers. An initial importer may fulfill its listing obligation, for a device it did not design or relabel, by submitting the manufacturer's name and address rather than full listing information.
Part 807 defines the initial importer as the importer that furthers the marketing of a device from a foreign manufacturer to the person who makes the final sale, without repackaging or relabeling it (§ 807.3(g)). That party registers its establishment. Registration and listing go through FDA's electronic device registration and listing system (§ 807.21), and the foreign establishment that makes the device registers and lists as well (§ 807.40).
The calendar matters. Annual registration runs from October 1 through December 31 of each FDA fiscal year; updates to registration information are due within 30 days of a change; and device listings are reviewed and updated in that same October-to-December window (§ 807.21). A lapsed listing is the kind of gap that surfaces at entry rather than in the office.
Registration and listing are an identity-and-inventory step, not a quality verdict. The rule states plainly that registration and listing do not amount to FDA approval, clearance, or a determination that a product is safe or even that it is a device. A separate premarket pathway — approval for a drug, or clearance or approval for a device — can still apply and is a different question entirely.
These two requirements cover drugs and medical devices. Cosmetics, food, and other product types answer to different FDA rules, so a product that is not a drug or a device is not addressed by Part 207 or Part 807 — which does not mean it is free of FDA requirements, only that the answer lies elsewhere.
The free Compliance Requirement Check routes a drug or medical-device product to the FDA registration and listing requirements that apply, and cites the rule — alongside the CPSC and FCC checks for the same product.
Run the free Certificate Requirement Check →The rules on this page do change — an eFiling date, a list, a threshold. Leave an email and a short note goes out if one does: a few a year at most, one click to stop, and the address is used for nothing else. A summary of the guide and a link arrive now, as confirmation.
Information current as of 2026-09-21.
This report is an automated, informational screening tool only. Tiana & Co. is not a licensed customs broker and does not conduct customs business. This report does not constitute legal advice, a compliance determination, or a certification of admissibility for any supplier, product, or shipment.
Verdicts in this report are produced by deterministic code, not by a language model. The explanatory paragraph accompanying each check is model-generated and checked against the cited sources before delivery. No part of this report is reviewed by a person before it is issued, so every material finding and citation should be confirmed against the underlying government source before it is relied on.
This report reflects data available as of the report date. The OFAC SDN and Consolidated lists, the other U.S. Consolidated Screening List constituents, the UFLPA Entity List, CBP withhold release orders, CPSC's eFiling list, and regulatory guidance are updated frequently and without prior notice. Users should re-screen periodically and consult qualified counsel for compliance decisions.
Name-similarity results do not establish or rule out the identity of any company. Where multiple similarly named records exist, none should be treated as confirmed without independent verification against the primary government source.
This tool is not affiliated with, endorsed by, or a substitute for U.S. Customs and Border Protection, the U.S. Department of the Treasury, the Consumer Product Safety Commission, or any other government agency. No warranty is made as to the accuracy, completeness, or currency of any finding.
Use of this report for import, procurement, sanctions-compliance, or investment decisions is at the user's own risk. Anyone with compliance obligations under UFLPA, OFAC, or CPSC regulations should consult qualified legal counsel before making a transactional decision.
This report is an automated, informational screening tool only. Tiana & Co. is not a licensed customs broker and does not conduct customs business. This report does not constitute legal advice, a compliance determination, or a certification of admissibility for any supplier, product, or shipment.
Verdicts in this report are produced by deterministic code, not by a language model. The explanatory paragraph accompanying each check is model-generated and checked against the cited sources before delivery. No part of this report is reviewed by a person before it is issued, so every material finding and citation should be confirmed against the underlying government source before it is relied on.
This report reflects data available as of the report date. The OFAC SDN and Consolidated lists, the other U.S. Consolidated Screening List constituents, the UFLPA Entity List, CBP withhold release orders, CPSC's eFiling list, and regulatory guidance are updated frequently and without prior notice. Users should re-screen periodically and consult qualified counsel for compliance decisions.
Name-similarity results do not establish or rule out the identity of any company. Where multiple similarly named records exist, none should be treated as confirmed without independent verification against the primary government source.
This tool is not affiliated with, endorsed by, or a substitute for U.S. Customs and Border Protection, the U.S. Department of the Treasury, the Consumer Product Safety Commission, or any other government agency. No warranty is made as to the accuracy, completeness, or currency of any finding.
Use of this report for import, procurement, sanctions-compliance, or investment decisions is at the user's own risk. Anyone with compliance obligations under UFLPA, OFAC, or CPSC regulations should consult qualified legal counsel before making a transactional decision.